STADA health products

STADA is a leading manufacturer of high-quality pharmaceuticals and consumer healthcare products. Founded in Germany in the late 19th century, the company has evolved from a local pharmacists' cooperative into a global healthcare player with a presence in approximately 120 countries.

The company follows a three-pillar strategy consisting of consumer healthcare products, generics, and specialty medicines (including biosimilars). While its roots and headquarters remain in Germany, STADA operates a vast international production network with facilities located in countries such as Germany, Serbia, Vietnam, and Russia to serve global markets.

In terms of ownership, STADA underwent a major transition in 2017 when it was acquired by investment firms Bain Capital and Cinven. This private equity ownership has focused on expanding the company's product portfolio and international footprint, positioning it as a major competitor in the European pharmaceutical landscape.